MR. MARIO R VELASCO MD NPI 1326007782

NPI Details

MR. Mario R Velasco, MD is a medical oncology internal medicine in Decatur, IL with 26 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. MR. Mario R Velasco, MD NPI is 1326007782. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL AT DALLAS
Graduation Year:2000

The provider's business location address is:

210 W MCKINLEY AVE
SUITE 1
DECATUR, IL
ZIP 62526
Phone: (217) 876-6600
Fax: (217) 876-6606

The NPI 1326007782 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Magnesium level (HCPCS:83735)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Red blood count, automated test (HCPCS:85045)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Folic acid level, serum (HCPCS:82746)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Injection of drug or substance into vein (HCPCS:96374)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Ct scan of chest with contrast (HCPCS:71260)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Vitamin d-3 level (HCPCS:82306)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Injection, midazolam hydrochloride, per 1 mg (HCPCS:J2250)
• Collection of blood sample from implanted device (HCPCS:36591)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Phosphate level (HCPCS:84100)
• Ct scan of chest without contrast (HCPCS:71250)
• Uric acid level, blood (HCPCS:84550)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Kidney function blood test panel (HCPCS:80069)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Injection, lorazepam, 2 mg (HCPCS:J2060)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Advance care planning, first 30 minutes (HCPCS:99497)
• Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
• Blood creatinine level (HCPCS:82565)

The enumeration date for this NPI number is 3/22/2006 and was last updated on 2/12/2014.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.